Project Details
Short title | Phase 11 trial of antologous dendritic cells transferred with a plasmid encoding melanocyte differentiation antigens using a non viral delivery system, CTL901 for the treatment of patients with metatastic melanoma. |
---|---|
Status | Finished |
Effective start/end date | 1/07/05 → 30/06/07 |
Funding
- THE MOULTON CHARITABLE TRUST